Human papillomavirus type 11 protein antigen (HPV-11 protein antigen)

Human papillomavirus type 11 (HPV-11) protein antigens refer collectively to the viral proteins encoded by the HPV-11 genome, with primary immunogenic importance attributed to the L1 protein as the major capsid antigen included in prophylactic HPV vaccines[5]. Specific proteins such as E1 (a DNA helicase) and E2 (a DNA-binding transcription/regulatory protein) are critical for viral replication and transcriptional regulation[1][2][3]. HPV-11 antigens stimulate host immune responses, providing the foundation for immunity and are essential for diagnostic and epidemiological purposes. As a target, the HPV-11 L1 protein is a major component of current HPV vaccines, while other proteins (E2, E1, E5, E7, and E6) play key roles in the viral life cycle and immune evasion. However, as a generic term, "HPV-11 protein antigen" is overly broad and not a specific molecular target, and should ideally be specified to the individual protein (e.g., HPV-11 L1, E2) for clarity and research utility[1][3][5]. Clarifications: - The term "Human papillomavirus type 11 protein antigen" is not a specific molecular entity but a generic grouping of immunogenic proteins produced by HPV-11; most research and clinical application focus on individual proteins and their roles (e.g., E2 for replication/transcription, L1 for vaccination)[1][3][5]. - For structured data or further research, it is strongly recommended to specify the individual HPV-11 protein.

Other names

HPV-11 antigenHPV type 11 antigenHPV-11 proteinHPV-11 E2HPV-11 E1HPV-11 L1HPV-11 L2

Vaccine-induced immunity: Neutralizing antibodies against HPV-11 L1 antigen prevent viral entry and infection; Not applicable for other drugs